629464295	629464295	CD	B-NP	O
|	|	NN	I-NP	O
LH	LH	NN	I-NP	O
|	|	NN	I-NP	O
87768480	87768480	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6362091	6362091	CD	B-NP	O
|	|	CC	I-NP	O
6/14/2005	6/14/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ROMI	ROMI	NN	I-NP	I-protein
,	,	,	O	O
pre-syncope/syncope	pre-syncope/syncope	JJ	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/18/2005	3/18/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/10/2005	9/10/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
MATTLER	MATTLER	NNP	B-NP	O
,	,	,	O	O
DEAN	DEAN	NNP	B-NP	O
K	K	NNP	I-NP	O
423-18-55-7	423-18-55-7	NNP	I-NP	O
West	West	NNP	I-NP	O
Sey	Sey	NNP	I-NP	O
A	A	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
10/21/05	10/21/05	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KAUS	KAUS	NNP	B-NP	O
,	,	,	O	O
AMBROSE	AMBROSE	NNP	B-NP	O
Z.	Z.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
AMA	AMA	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
CIPROFLOXACIN	CIPROFLOXACIN	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q12H	Q12H	NN	I-NP	O
X	X	SYM	B-VP	O
14	14	CD	B-NP	O
doses	dose	NNS	I-NP	O
Starting	Start	VBG	B-VP	O
IN	IN	IN	B-PP	O
AM	AM	NNP	B-NP	O
ON	ON	NNP	I-NP	O
1/11/2005	1/11/2005	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
09	09	CD	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
iron	iron	NN	I-NP	O
products	product	NNS	I-NP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

SYNTHROID	SYNTHROID	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
200	200	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/21/05	10/21/05	CD	B-NP	O
by	by	IN	B-PP	O
VANLEER	VANLEER	NN	B-NP	O
,	,	,	O	O
ALLAN	ALLAN	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
38280791	38280791	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/12/05	1/12/05	CD	B-NP	O
by	by	IN	B-PP	O
MONTAVON	MONTAVON	NNP	B-NP	O
,	,	,	O	O
ROCCO	ROCCO	NNP	B-NP	O
A	A	NNP	I-NP	O
HARVEY	HARVEY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
REL	REL	NNP	I-NP	O
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
95976633	95976633	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/12/05	1/12/05	CD	B-NP	O
by	by	IN	B-PP	O
ABPLANALP	ABPLANALP	NN	B-NP	O
,	,	,	O	O
ELIAS	ELIAS	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NN	B-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
47464979	47464979	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
60	60	CD	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/12/05	1/12/05	CD	B-NP	O
by	by	IN	B-PP	O
GADUE	GADUE	NNP	B-NP	O
,	,	,	O	O
WILTON	WILTON	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LOPRESSOR	LOPRESSOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

ROXICODONE	ROXICODONE	NN	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
OXYCODONE	OXYCODONE	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
5	5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q6H	Q6H	NN	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
PAROXETINE	PAROXETINE	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
NOVOLIN	NOVOLIN	NNP	I-NP	I-protein
INNOLET	INNOLET	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
HUMAN	HUMAN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
50	50	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
FS	FS	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
NOVOLIN	NOVOLIN	NNP	I-NP	O
INNOLET	INNOLET	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
HUMAN	HUMAN	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
25	25	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QHS	QHS	NNP	I-NP	I-protein
HOLD	HOLD	NNP	I-NP	I-protein
IF	IF	NNP	I-NP	I-protein
:	:	:	O	O
HOLD	HOLD	NN	B-NP	O
IF	IF	NN	I-NP	O
FS	FS	NN	I-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Needs	Need	VBZ	B-VP	O
walker/24	walker/24	NN	B-NP	O
asssitance	asssitance	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Rippentrop	Rippentrop	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
*	*	SYM	B-NP	O
MC	MC	NN	I-NP	O
PCP/Cardiologist	PCP/Cardiologist	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
11/19/05	11/19/05	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Penicillins	Penicillin	NNS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Syncope	Syncope	NN	B-NP	O
vs.	vs.	CC	O	O
mechanical	mechanical	JJ	B-NP	O
fall	fall	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ROMI	ROMI	NNP	I-NP	O
,	,	,	O	O
pre-syncope/syncope	pre-syncope/syncope	JJ	B-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
hypertension	hypertension	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
diabetes	diabete	VBZ	B-VP	O
-LRB-	-LRB-	NN	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
cva	cva	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
cerebrovascular	cerebrovascular	JJ	I-NP	O
accident	accident	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gerd	gerd	NN	I-NP	O
,	,	,	O	O
hyperparathyroidism	hyperparathyroidism	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
primary	primary	JJ	I-NP	O
hyperparathyroidism	hyperparathyroidism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
anemia	anemia	NN	I-NP	O
-	-	HYPH	B-ADJP	O
?	?	.	O	O

alpha	alpha	SYM	B-NP	O
thal	thal	JJ	I-NP	O
trait	trait	NN	I-NP	O
Chronic	Chronic	NNP	I-NP	O
LFT	LFT	NN	I-NP	O
elevation	elevation	NN	I-NP	O
s/p	s/p	NN	I-NP	O
complete	complete	JJ	I-NP	O
w/u	w/u	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
fatty	fatty	JJ	B-NP	O
liver	liver	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
NONE	NONE	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
MRI/MRA	MRI/MRA	NNP	I-NP	O
Brain	Brain	NNP	I-NP	O
-	-	:	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

Significant	Significant	JJ	B-NP	O
atherosclerotic	atherosclerotic	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Carotids	Carotid	NNS	B-NP	O
patent	patent	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
s/p	s/p	NN	B-NP	O
fall	fall	NN	I-NP	O
brought	bring	VBN	B-VP	O
in	in	RP	B-PRT	O
by	by	IN	B-PP	O
daughter	daughter	NN	B-NP	O
****	****	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
66	66	CD	B-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
w	w	NN	I-NP	O
DM	DM	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
CVA	CVA	NN	I-NP	O
w	w	NN	I-NP	O
dementia	dementia	NN	I-NP	O
,	,	,	O	O
neuropathy	neuropathy	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
and	and	CC	O	O
recent	recent	JJ	B-NP	O
falls	fall	NNS	I-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
fall	fall	NN	B-NP	O
,	,	,	O	O
Possible	Possible	JJ	B-NP	O
syncope	syncope	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
ED	ED	VBN	B-VP	O
on	on	IN	B-PP	O
9/10	9/10	CD	B-NP	O
for	for	IN	B-PP	O
falls	fall	NNS	B-NP	O
and	and	CC	O	O
left	left	JJ	B-NP	O
AMA	AMA	NN	I-NP	O
though	though	IN	B-SBAR	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
.	.	.	O	O

History	History	NN	B-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
family	family	NN	B-NP	O
and	and	CC	I-NP	O
pt	pt	NN	I-NP	O
--	--	:	O	O
but	but	CC	O	O
PT	PT	NN	B-NP	O
IS	IS	NN	I-NP	O
POOR	POOR	NN	I-NP	O
HISTORIAN	HISTORIAN	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
notes	note	VBZ	B-VP	O
falling	fall	VBG	I-VP	O
4	4	CD	B-NP	O
times	time	NNS	I-NP	O
in	in	IN	B-PP	O
last	last	JJ	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

Fell	Fell	NNP	B-NP	O
today	today	NN	B-NP	O
:	:	:	O	O
denies	deny	VBZ	B-VP	O
head	head	NN	B-NP	O
trauma	trauma	NN	I-NP	O
,	,	,	O	O
denies	deny	VBZ	B-VP	O
LH	LH	NN	B-NP	O
and	and	CC	I-NP	O
reports	report	NNS	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
n't	n't	RB	I-VP	O
know	know	VB	I-VP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
falling	fall	VBG	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
notes	note	NNS	I-NP	O
increased	increase	VBD	B-VP	O
Rt	Rt	NN	B-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
worse	worse	JJR	B-ADJP	O
from	from	IN	B-PP	O
after	after	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
;	;	:	O	O
Doctor	Doctor	NNP	B-NP	O
notes	note	VBZ	B-VP	O
poor	poor	JJ	B-NP	O
appetite	appetite	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
recent	recent	JJ	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

Doctor	Doctor	NNP	B-NP	O
says	say	VBZ	B-VP	O
pt	pt	NN	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
``	``	``	O	O
total	total	JJ	B-NP	O
body	body	NN	I-NP	O
pain	pain	NN	I-NP	O
''	''	''	O	O
and	and	CC	O	O
worsening	worsen	VBG	B-VP	O
Rt	Rt	NN	B-NP	B-protein
sided	sided	JJ	I-NP	I-protein
weakness	weakness	NN	I-NP	I-protein
x2	x2	NN	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
F/C/sweats	F/C/sweat	NNPS	I-NP	O
/	/	SYM	I-NP	O
diarrea	diarrea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
FS	FS	NNS	B-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
42-90s	42-90	NNS	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
denies	deny	VBZ	B-VP	O
vertigo	vertigo	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
uses	use	VBZ	B-VP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
way	way	NN	I-NP	O
to	to	TO	B-PP	O
ED	ED	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
c/o	c/o	VBD	B-VP	O
chest	chest	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
to	to	TO	B-PP	O
EMS	EMS	NNP	B-NP	O
:	:	:	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
lasix	lasix	NN	I-NP	O
,	,	,	O	O
morphine	morphine	NN	B-NP	O
,	,	,	O	O
lopressor	lopressor	NN	B-NP	O
.	.	.	O	O

Per	Per	NN	B-NP	O
daughter	daughter	NN	I-NP	O
pt	pt	NN	I-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
had	have	VBN	I-VP	O
CP	CP	NN	B-NP	B-DNA
,	,	,	O	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
used	use	VBN	I-VP	O
NTG	NTG	NN	B-NP	B-protein
since	since	IN	B-PP	O
6/27	6/27	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
YG	YG	NNP	B-NP	O
ED	ED	NNP	I-NP	O
,	,	,	O	O
VSS	VSS	NN	B-NP	B-protein
,	,	,	O	O
gluc	gluc	NN	B-NP	O
82	82	CD	I-NP	O
,	,	,	O	O
K	K	NN	B-NP	B-cell_line
3.1	3.1	NN	I-NP	I-cell_line
,	,	,	O	O
ECG	ECG	NN	B-NP	O
w	w	NN	I-NP	O
flat	flat	JJ	I-NP	O
T	T	NN	I-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
2-5	2-5	NN	B-NP	O
and	and	CC	I-NP	O
v3-v6	v3-v6	NN	I-NP	O
.	.	.	O	O

UA	UA	NN	B-NP	O
w	w	NN	I-NP	O
>	>	SYM	B-NP	O
60	60	CD	B-NP	O
WBC	WBC	NN	I-NP	O
suggesting	suggest	VBG	B-VP	O
UTI	UTI	NN	B-NP	O
.	.	.	O	O

Patient	Patient	JJ	B-NP	O
given	give	VBN	I-NP	O
levaquin	levaquin	NN	I-NP	O
.	.	.	O	O

***	***	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
CVA	CVA	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
w	w	NN	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
;	;	:	O	O
h/o	h/o	NN	B-NP	O
dialysis	dialysis	NN	I-NP	O
in	in	IN	B-PP	O
2004	2004	CD	B-NP	O
;	;	:	O	O
falls	fall	NNS	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
GERD	GERD	NNP	B-NP	O
***	***	NNP	I-NP	O
MEDs	MEDs	NNP	I-NP	O
:	:	:	O	O
novolin	novolin	NN	B-NP	O
insulin	insulin	NN	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
,	,	,	O	O
nexium	nexium	NN	B-NP	O
,	,	,	O	O
asa	asa	NN	B-NP	O
***	***	SYM	B-NP	O
STUDIES	STUDIES	NN	I-NP	O
:	:	:	O	O
CXR	CXR	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
w	w	NN	I-NP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
9/10	9/10	CD	I-NP	O
hip/pelvic	hip/pelvic	JJ	I-NP	O
films	film	NNS	I-NP	O
neg	neg	NN	I-NP	O
for	for	IN	B-PP	O
fx	fx	NN	B-NP	O
DAILY	DAILY	NN	I-NP	O
STATUS	STATUS	NN	I-NP	O
:	:	:	O	O
7/26	7/26	CD	B-NP	O
pt	pt	NN	I-NP	O
hemodyn	hemodyn	NN	I-NP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
confused	confuse	VBN	B-VP	O
;	;	:	O	O
slowed	slow	VBD	B-VP	O
slurred	slur	VBD	B-VP	O
speech	speech	NN	B-NP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
***	***	SYM	B-NP	O
A/P	A/P	NN	I-NP	O
:	:	:	O	O
66	66	CD	B-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
w	w	NN	I-NP	O
DM	DM	NN	I-NP	O
,	,	,	O	O
atherosclerosis	atherosclerosis	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
dementia	dementia	NN	B-NP	O
admitted	admit	VBD	B-VP	O
w	w	NN	B-NP	O
for	for	IN	B-PP	O
falls	fall	NNS	B-NP	O
.	.	.	O	O

Workup	Workup	NNP	B-NP	O
includes	include	VBZ	B-VP	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
vs.	vs.	CC	B-PP	O
syncope	syncope	NN	B-NP	O
vs.	vs.	CC	O	O
dehydration	dehydration	NN	B-NP	O
vs.	vs.	CC	B-PP	O
hypoglycemia	hypoglycemia	NN	B-NP	O
vs.	vs.	IN	B-PP	O
UTI	UTI	NNP	B-NP	O
vs.	vs.	CC	O	O
mechanical	mechanical	JJ	B-NP	O
fall	fall	NN	I-NP	O
vs.	vs.	IN	B-PP	O
new	new	JJ	B-NP	O
stroke	stroke	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
-	-	HYPH	B-PP	O
known	know	VBN	B-NP	O
CAD	CAD	NN	I-NP	B-protein
;	;	:	O	O
no	no	DT	B-NP	O
recent	recent	JJ	I-NP	O
stress	stress	NN	I-NP	O
imaging	imaging	NN	I-NP	O
or	or	CC	I-NP	O
echo	echo	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
ROMI	ROMI	VB	I-VP	O
and	and	CC	O	O
consider	consider	VB	B-VP	O
risk	risk	NN	B-NP	O
stratification	stratification	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
ASA	ASA	NNP	I-NP	O
,	,	,	O	O
BB	BB	NNP	B-NP	O
,	,	,	O	O
?	?	.	O	O

statin	statin	NN	B-NP	O
.	.	.	O	O

Performed	Perform	VBN	B-NP	O
serial	serial	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
x	x	NN	I-NP	O
2	2	CD	I-NP	O
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
x	x	NN	B-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Patient	Patient	NN	B-NP	O
refused	refuse	VBD	B-VP	O
third	third	JJ	B-NP	O
set	set	NN	I-NP	O
and	and	CC	I-NP	O
3rd	3rd	NN	I-NP	O
ekg	ekg	NN	I-NP	O
after	after	IN	B-PP	O
explaining	explain	VBG	B-VP	O
risks/benefits	risks/benefit	NNS	B-NP	O
.	.	.	O	O

PUMP-mildly	PUMP-mildly	JJ	B-NP	O
hypovol	hypovol	NN	I-NP	O
by	by	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

hydrate	hydrate	NN	B-NP	O
gently	gently	RB	I-NP	O
w	w	NN	I-NP	O
IVF	IVF	NN	I-NP	O
.	.	.	O	O

Echo	Echo	NN	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
if	if	IN	B-SBAR	O
not	not	RB	O	O
had	have	VBD	B-VP	O
one	one	CD	B-NP	O
recently	recently	RB	B-ADVP	O
.	.	.	O	O

Rhythm-on	Rhythm-on	JJ	B-NP	O
tele	tele	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
also	also	RB	B-ADVP	O
hypokelamic	hypokelamic	JJ	B-NP	O
,	,	,	I-NP	O
hypophosphatemic	hypophosphatemic	JJ	I-NP	O
.	.	.	O	O

Hypomag	Hypomag	NN	B-NP	O
.	.	.	O	O

Refused	Refuse	VBN	B-NP	O
repletion	repletion	NN	I-NP	O
after	after	IN	B-PP	O
explained	explain	VBN	B-NP	O
risks/benefits	risks/benefit	NNS	I-NP	O
.	.	.	O	O

Discussed	Discuss	VBN	B-VP	O
with	with	IN	B-PP	O
HCP	HCP	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
son	son	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
and	and	CC	O	O
patient	patient	NN	B-NP	O
refused	refuse	VBD	B-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

GU-Levaquin	GU-Levaquin	NN	B-NP	O
for	for	IN	B-PP	O
UTI	UTI	NN	B-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
Cipro	Cipro	NNP	B-NP	O
BID	BID	NNP	I-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
for	for	IN	B-PP	O
10	10	CD	B-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
agreed	agree	VBD	B-VP	O
to	to	TO	I-VP	O
take	take	VB	I-VP	O
this	this	DT	B-NP	O
.	.	.	O	O

Understood	Understood	NN	B-NP	O
risks	risk	NNS	I-NP	O
and	and	CC	I-NP	O
benefits	benefit	NNS	I-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
ur	ur	JJ	B-NP	O
cx	cx	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

Explicitly	Explicitly	RB	B-NP	O
encouraged	encouraged	JJ	I-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
and	and	CC	O	O
also	also	RB	B-VP	O
reiterated	reiterate	VBD	I-VP	O
to	to	TO	I-VP	O
daughter	daughter	VB	I-VP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
taking	take	VBG	I-VP	O
patient	patient	NN	B-NP	O
home	home	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

PULM-stable	PULM-stable	JJ	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Neuro	Neuro	SYM	O	O
-	-	:	O	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
weakness	weakness	NN	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
UTI	UTI	NN	B-NP	B-DNA
,	,	,	O	O
but	but	CC	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
family	family	NN	B-NP	O
's	's	POS	B-NP	O
continued	continued	JJ	I-NP	O
assessment	assessment	NN	I-NP	O
.	.	.	O	O

Doubt	Doubt	NN	B-NP	O
seizure	seizure	NN	I-NP	O
.	.	.	O	O

MRI/MRA	MRI/MRA	NN	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
acute	acute	JJ	B-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
new	new	JJ	I-NP	O
stroke	stroke	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
;	;	:	O	O
s	s	NNS	B-NP	O
family	family	NN	I-NP	O
and	and	CC	I-NP	O
HCP	HCP	NN	I-NP	O
states	state	NNS	I-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
at	at	IN	B-PP	O
mental	mental	JJ	B-NP	O
baseline	baseline	NN	I-NP	O
for	for	IN	B-PP	O
years	year	NNS	B-NP	O
.	.	.	O	O

Falls	Fall	NNS	B-NP	O
originally	originally	RB	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secndary	secndary	JJ	B-ADJP	O
to	to	TO	B-PP	O
neuropathy	neuropathy	JJ	B-ADJP	O
vs	vs	IN	B-PP	O
new	new	JJ	B-NP	O
CVA	CVA	NN	I-NP	O
vs	vs	IN	B-PP	O
hypokalemia	hypokalemia	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
refused	refuse	VBD	B-VP	O
potassium	potassium	NN	B-NP	O
repletion	repletion	NN	I-NP	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
monitor	monitor	NN	I-NP	O
FS	FS	NN	I-NP	O
closely	closely	RB	B-ADVP	O
,	,	,	O	O
check	check	VB	B-VP	O
thyroid	thyroid	JJ	B-NP	O
panel	panel	NN	I-NP	O
.	.	.	O	O

Instructed	Instruct	VBN	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-PP	O
also	also	RB	B-NP	O
half	half	JJ	I-NP	O
insulin	insulin	NN	I-NP	O
dose	dose	NN	I-NP	O
as	as	IN	B-SBAR	O
hypoglycemia	hypoglycemia	NN	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-NP	O
possibility	possibility	NN	I-NP	O
that	that	WDT	B-NP	O
contributes	contribute	VBZ	B-VP	O
to	to	TO	B-PP	O
weakness	weakness	NN	B-NP	O
.	.	.	O	O

INstructed	INstructe	VBN	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-VP	O
discuss	discuss	VB	I-VP	O
new	new	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Pelkey	Pelkey	NNP	I-NP	O
regarding	regard	VBG	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
stated	state	VBD	B-VP	O
she	she	PRP	B-NP	O
understood	understand	VBD	B-VP	O
and	and	CC	O	O
wil	wil	NN	B-NP	O
do	do	VBP	B-VP	O
so	so	RB	B-ADVP	O
.	.	.	O	O

Discharged	Discharge	VBN	B-VP	O
on	on	IN	B-PP	O
instructions	instruction	NNS	B-NP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
half	half	NN	B-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
dose	dose	NN	I-NP	O
in	in	IN	B-PP	O
morning	morning	NN	B-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
PM	PM	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

PT	PT	NN	B-NP	O
Consult	Consult	NN	I-NP	O
-	-	HYPH	B-NP	O
PT	PT	NN	I-NP	O
cleared	clear	VBD	B-VP	O
patient	patient	NN	B-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
home	home	NN	B-NP	O
PT	PT	NN	I-NP	O
,	,	,	O	O
already	already	RB	B-ADVP	O
set	set	VBN	B-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

DISPO	DISPO	NN	B-NP	B-protein
-	-	HYPH	I-NP	O
patient	patient	NN	I-NP	O
signed	sign	VBN	B-VP	O
out	out	RP	B-PRT	O
AMA	AMA	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
advised	advise	VBD	B-VP	O
patient	patient	NN	B-NP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
blood	blood	NN	B-NP	O
drawn	drawn	NN	I-NP	O
and	and	CC	O	O
electrolytes	electrolyte	NNS	B-NP	O
repleted	replete	VBN	B-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
refused	refuse	VBD	B-VP	O
.	.	.	O	O

Understood	Understood	JJ	B-NP	O
risks	risk	NNS	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
refused	refuse	VBN	B-VP	O
to	to	TO	I-VP	O
stay	stay	VB	I-VP	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
workup	workup	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
kind	kind	NN	I-NP	O
and	and	CC	O	O
understood	understand	VBN	B-NP	O
risks	risk	NNS	I-NP	O
.	.	.	O	O

Wrote	Wrote	JJ	B-NP	O
prescriptions	prescription	NNS	I-NP	O
and	and	CC	O	O
instructed	instruct	VBN	B-VP	O
patient	patient	NN	B-NP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
see	see	VB	I-VP	O
PCP	PCP	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Nisbet	Nisbet	NNP	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Gave	Gave	VB	B-VP	O
ateint	ateint	NN	B-NP	O
prescriptions	prescription	NNS	I-NP	O
ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
PT	PT	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	I-NP	O
VNA	VNA	NN	I-NP	B-protein
at	at	IN	B-PP	O
home	home	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
reinstated	reinstate	VBN	I-VP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Satisfactory	Satisfactory	JJ	B-ADJP	O
TO	TO	TO	B-VP	O
DO/PLAN	DO/PLAN	NN	I-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
go	go	VB	I-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Bajaj	Bajaj	NNP	I-NP	O
EMH	EMH	NNP	I-NP	O
at	at	IN	B-PP	O
11/19/05	11/19/05	CD	B-NP	O
or	or	CC	O	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
go	go	VB	B-VP	O
to	to	TO	B-PP	O
nearest	near	JJS	B-NP	O
ER	ER	NN	I-NP	B-protein
if	if	IN	B-SBAR	O
experiencing	experience	VBG	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
2	2	CD	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
Ciprofloxacin	Ciprofloxacin	NN	B-NP	O
as	as	IN	B-PP	O
prescribed	prescribe	VBN	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
half	half	PDT	I-NP	O
the	the	DT	I-NP	O
insulin	insulin	NN	I-NP	O
dose	dose	NN	I-NP	O
in	in	IN	B-PP	O
AM	AM	NN	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

Do	Do	NNP	B-NP	O
fingersticks	fingerstick	VBZ	B-VP	O
regularly	regularly	RB	B-ADVP	O
before	before	IN	B-PP	O
giving	give	VBG	B-VP	O
insulin	insulin	NN	B-NP	B-protein
.	.	.	O	O

Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
give	give	VB	I-VP	O
insulin	insulin	NN	B-NP	B-protein
if	if	IN	B-SBAR	O
fingerstick	fingerstick	NN	B-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-DNA
5	5	CD	I-NP	I-DNA
.	.	.	O	O

Resume	Resume	NN	B-NP	O
VNA	VNA	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
INGWERSEN	INGWERSEN	NNP	B-NP	O
,	,	,	O	O
RICKIE	RICKIE	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LK23	LK23	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/21/05	10/21/05	CD	I-NP	O
@	@	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

